Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10775 | 31197983 | J Korean Med Sci | Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A10811 | 31177658 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy]. | 2019 | Details |
| A10849 | 31157605 | J Am Coll Nutr | Association Between Dietary Selenium Intake and the Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2019 | Details |
| A10857 | 31153702 | J Vasc Surg | The association between liver fat and systemic calcified atherosclerosis. | 2019 | Details |
| A10870 | 32818162 | Curr Opin Physiol | Redox Regulation of Metabolic Syndrome: Recent Developments in Skeletal Muscle Insulin Resistance and Non-alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A10891 | 31137547 | Medicina (Kaunas) | Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10897 | 31135513 | Eur J Gastroenterol Hepatol | Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10906 | 31131357 | Ann Gastroenterol Surg | Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients. | 2019 | Details |
| A10907 | 31131153 | Am J Cardiovasc Dis | Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits. | 2019 | Details |
| A10955 | 31104631 | BMC Med | Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. | 2019 | Details |
| A10956 | 31104523 | Expert Rev Gastroenterol Hepatol | A critical appraisal of the use of ultrasound in hepatic steatosis. | 2019 | Details |
| A10960 | 31101783 | Georgian Med News | RESULTS OF CORRECTION OF THE HEPATIC STEATOSIS ON THE BACKGROUND OF HYPERTENSION AND OVERWEIGHT WITH HELP OF ESSENTIAL PHOSPHOLIPID COMPLEX. | 2019 | Details |
| A10978 | 31094181 | Ter Arkh | Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy. | 2019 | Details |
| A10982 | 31093446 | Food Sci Biotechnol | Green satsuma mandarin orange (Citrus unshiu) extract reduces adiposity and induces uncoupling protein expression in skeletal muscle of obese mice. | 2018 | Details |
| A11057 | 31064058 | Int J Mol Sci | Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11072 | 31057993 | Cureus | Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. | 2019 | Details |
| A11106 | 31040024 | Atherosclerosis | No association between aortic stiffness and liver steatosis in morbidly obese patients. | 2019 | Details |
| A11120 | 31033805 | J Clin Gastroenterol | Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B. | 2020 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11168 | 31013163 | Endocr Pract | FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES. | 2019 | Details |
| A11179 | 31009793 | Clin Gastroenterol Hepatol | Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. | 2019 | Details |
| A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11224 | 30987010 | J Clin Med | Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study. | 2019 | Details |
| A11238 | 30978698 | J Mol Endocrinol | Humulus japonicus stimulates thermogenesis and ameliorates oxidative stress in mouse adipocytes. | 2019 | Details |
| A11240 | 30978266 | PLoS One | Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. | 2019 | Details |
| A11294 | 30951517 | Am J Gastroenterol | An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome. | 2019 | Details |
| A11345 | 30928957 | BMJ Open | Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population. | 2019 | Details |
| A11362 | 30922067 | Cell Transplant | Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11387 | 30916873 | Liver Int | Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients. | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11469 | 30882706 | Medicine (Baltimore) | Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study. | 2019 | Details |
| A11488 | 30875495 | Atherosclerosis | Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. | 2019 | Details |
| A11489 | 30875494 | Atherosclerosis | Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. | 2019 | Details |
| A11501 | 30868786 | J Ayub Med Coll Abbottabad | Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid. | 2019 | Details |
| A11564 | 30837878 | Front Pharmacol | G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. | 2019 | Details |
| A11589 | 30827909 | Endocrinol Diabetes Nutr (Engl Ed) | Document on a comprehensive approach to type 2 diabetes mellitus. | 2019 | Details |
| A11591 | 30826597 | Nutrition | Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults. | 2018 | Details |
| A11633 | 30810330 | Rev Esp Enferm Dig | Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11636 | 30809932 | Liver Int | Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients. | 2019 | Details |
| A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11725 | 30775610 | Arch Med Sci Atheroscler Dis | Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study. | 2018 | Details |
| A11728 | 30774403 | Diabetes Metab Syndr Obes | The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. | 2019 | Details |
| A11745 | 30768879 | Klin Lab Diagn | [The person in philogenesis is not (omnivores), but the herbivores with the carnivores past and the fuzzy future. Biological function of trophology (nutrition) in ontogenesis.] | 2019 | Details |
| A11748 | 30767421 | Diabetes Metab Res Rev | The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis. | 2019 | Details |
| A11758 | 30763699 | Diabetes Metab | Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. | 2019 | Details |
| A11792 | 30740871 | Diabetes Metab Res Rev | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. | 2019 | Details |
| A11806 | 30732555 | Eur J Sport Sci | Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. | 2019 | Details |
| A11855 | 30707282 | J Gastroenterol | Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis. | 2019 | Details |
| A11863 | 30705499 | Clin Diabetes | Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality. | 2019 | Details |
| A11902 | 30687780 | Hepatoma Res | Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. | 2018 | Details |
| A11920 | 30681879 | MSMR | Non-alcoholic fatty liver disease (NAFLD), active component, U.S. Armed Forces, 2000-2017. | 2019 | Details |
| A11960 | 30667551 | J Gastroenterol Hepatol | Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11987 | 30657626 | Liver Int | Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. | 2019 | Details |
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A11992 | 30654392 | Semin Liver Dis | NASH in Lean Individuals. | 2019 | Details |
| A12003 | 30651891 | Genes Nutr | Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study. | 2019 | Details |
| A12022 | 30640271 | J Pediatr Gastroenterol Nutr | Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States. | 2019 | Details |
| A12045 | 30625487 | Dig Dis | Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12064 | 30618391 | Georgian Med News | [ANTHROPOMETRIC CHARACTERISTICS AND PARAMETERS OF LIPID-CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION DEPENDING ON THE DEGREE OF HEPATIC STEATOSIS]. | 2018 | Details |
| A12088 | 30607652 | Clin Rheumatol | Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. | 2019 | Details |
| A12104 | 30600551 | J Gastroenterol Hepatol | HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. | 2019 | Details |
| A12109 | 30599172 | J Hepatol | Gap junctions in liver disease: Implications for pathogenesis and therapy. | 2018 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12174 | 30574460 | Eur Thyroid J | Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria. | 2018 | Details |
| A12213 | 30560336 | Dig Dis Sci | Incidence of Recurrent NASH-Related Allograft Cirrhosis. | 2018 | Details |
| A12258 | 30543782 | Chem Biol Interact | Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states. | 2018 | Details |
| A12272 | 30539516 | Hepatol Int | Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. | 2018 | Details |
| A12344 | 30498904 | J Gastroenterol | A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update. | 2018 | Details |
| A12369 | 30483562 | JGH Open | Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh. | 2018 | Details |
| A12377 | 30479664 | Therap Adv Gastroenterol | Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. | 2018 | Details |
| A12382 | 30476583 | Clin Gastroenterol Hepatol | Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. | 2018 | Details |
| A12385 | 30474191 | Diabet Med | Utility of HbA1c assessment in people with diabetes awaiting liver transplantation. | 2019 | Details |
| A12411 | 30466676 | Med Clin North Am | The Future of Nonalcoholic Fatty Liver Disease Treatment. | 2018 | Details |
| A12454 | 30448600 | Clin Gastroenterol Hepatol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis. | 2018 | Details |
| A12478 | 30430519 | Tunis Med | Estimation of the prevalence of obstructive sleep apnea in non alcoholic fatty liver disease. | 2018 | Details |
| A12489 | 30427105 | Liver Int | Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. | 2018 | Details |
| A12499 | 30420265 | Arab J Gastroenterol | Managing diabetes and liver disease association. | 2018 | Details |
| A12516 | 30412101 | Medicine (Baltimore) | The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients. | 2018 | Details |
| A12525 | 30411081 | Hepatol Commun | Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12536 | 30403898 | J Dermatolog Treat | Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies. | 2018 | Details |
| A12544 | 30400736 | Gut Liver | Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12551 | 30394863 | Metab Syndr Relat Disord | Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. | 2018 | Details |
| A12642 | 30353552 | Aliment Pharmacol Ther | The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. | 2018 | Details |
| A12650 | 30347513 | Liver Int | Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A12664 | 30338761 | Gen Physiol Biophys | Effect of metabolic syndrome on neural plasticity and morphology of the hippocampus: correlations of neurological deficits with physiological status of the rat. | 2018 | Details |
| A12666 | 30338113 | Obes Sci Pract | Association of time of obesity onset with comorbidities in treatment-seeking men and women with severe obesity. | 2018 | Details |
| A12671 | 30335697 | Transplantation | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. | 2019 | Details |
| A12699 | 30323178 | Sci Rep | Association between body mass index and fatty liver risk: A dose-response analysis. | 2018 | Details |
| A12707 | 30319417 | Front Pharmacol | The Role of Gut Microbiota in Atherosclerosis and Hypertension. | 2018 | Details |
| A12711 | 30318607 | Hepatology | Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension. | 2019 | Details |
| A12733 | 30312513 | Liver Int | Potential mechanisms linking gut microbiota and portal hypertension. | 2018 | Details |
| A12783 | 30288767 | Aliment Pharmacol Ther | Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany. | 2018 | Details |
| A12785 | 30288477 | Hepatol Commun | Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. | 2018 | Details |
| A12789 | 30287733 | Nutrients | Achacha (Garcinia humilis) Rind Improves Cardiovascular Function in Rats with Diet-Induced Metabolic Syndrome. | 2018 | Details |
| A12865 | 30249980 | Diseases | Judicious Use of Lipid Lowering Agents in the Management of NAFLD. | 2018 | Details |
| A12876 | 30246712 | Chin Med J (Engl) | Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: A Cross-Sectional Study. | 2018 | Details |